DRIO logo

DarioHealth (DRIO) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

14 March 2016

Indexes:

Not included

Description:

DarioHealth (DRIO) is a digital health company that offers personalized solutions for managing chronic conditions like diabetes. Their platform provides tools for monitoring health, accessing data, and receiving support, helping users improve their well-being and make informed decisions about their health.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 07, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 18, 2019

Analyst ratings

Recent major analysts updates

01 Apr '24 Stifel
Buy
11 Aug '23 Alliance Global Partners
Buy
25 July '23 Stifel
Buy
12 May '23 Craig-Hallum
Buy
16 Nov '22 Alliance Global Partners
Buy
18 Aug '22 Aegis Capital
Buy
16 Aug '22 Cowen & Co.
Outperform
16 May '22 Cowen & Co.
Outperform
16 May '22 Aegis Capital
Buy
13 May '22 Alliance Global Partners
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
DRIO
seekingalpha.com09 November 2024

DarioHealth Corp. (NASDAQ:DRIO ) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Third Quarter 2024 Results Call. [Operator Instructions] This call is being recorded on November 7, 2024.

DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates
DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates
DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates
DRIO
zacks.com07 November 2024

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.49 per share a year ago.

Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population
Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population
Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population
DRIO
prnewswire.com30 October 2024

The new contract marks the eighth health plan for Dario and will contribute to revenues starting immediately. NEW YORK , Oct. 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract with a regional health plan in the Medicaid space, which has launched with the full suite of cardiometabolic solutions.

DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th
DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th
DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th
DRIO
prnewswire.com23 October 2024

Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 23, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a global leader in digital health, announced today that it will release its financial results for the 3rd quarter ended September 30th, 2024 and will host a conference call and webcast at 8:30 am Eastern Time, on Thursday, November 7th, 2024, before the market opens.     Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call.

Twill by Dario to Offer a Benefit for AARP Members
Twill by Dario to Offer a Benefit for AARP Members
Twill by Dario to Offer a Benefit for AARP Members
DRIO
prnewswire.com15 October 2024

New offer gives Dario access to millions of AARP members, enabling engagement with people over 50 in health and well-being beginning in January 2025 NEW YORK , Oct. 15, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new AARP member benefit that provides members with proven digital behavioral health and well-being solutions from Twill by Dario. The new benefit is expected to launch in January of 2025 for AARP members.

All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy
DRIO
zacks.com02 October 2024

DarioHealth (DRIO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Bet on 5 Top-Ranked Stocks With Rising P/E
Bet on 5 Top-Ranked Stocks With Rising P/E
Bet on 5 Top-Ranked Stocks With Rising P/E
DRIO
zacks.com02 October 2024

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Adverum Biotechnologies (ADVM), IceCure Medical (ICCM), DarioHealth (DRIO), Energous (WATT) and Virgin Galactic (SPCE).

DarioHealth And 2 Other Stocks Under $5 Executives Are Buying
DarioHealth And 2 Other Stocks Under $5 Executives Are Buying
DarioHealth And 2 Other Stocks Under $5 Executives Are Buying
DRIO
benzinga.com13 September 2024

The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes
Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes
Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes
DRIO
prnewswire.com12 September 2024

The integration of Twill's condition-specific, expert-led peer groups will enhance the member experience and deepen engagement with Dario's proven cardiometabolic solution NEW YORK , Sept. 12, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market announced today the integration of condition-specific communities and peer groups with personalized navigation capabilities into its cardiometabolic solution to improve outcomes-based engagement, marking a significant milestone in the integration of the Dario-Twill product offering.

Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
DRIO
prnewswire.com10 September 2024

New Research Confirms the Benefit of Dario's Integrated, Data-Driven Approach to Health and Chronic Condition Management NEW YORK , Sept. 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market announced today the publication of a new study in the peer-reviewed journal Frontiers in Endocrinology.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of DarioHealth?
  • What is the ticker symbol for DarioHealth?
  • Does DarioHealth pay dividends?
  • What sector is DarioHealth in?
  • What industry is DarioHealth in?
  • What country is DarioHealth based in?
  • When did DarioHealth go public?
  • Is DarioHealth in the S&P 500?
  • Is DarioHealth in the NASDAQ 100?
  • Is DarioHealth in the Dow Jones?
  • When was DarioHealth's last earnings report?
  • When does DarioHealth report earnings?
  • Should I buy DarioHealth stock now?

What is the primary business of DarioHealth?

DarioHealth (DRIO) is a digital health company that offers personalized solutions for managing chronic conditions like diabetes. Their platform provides tools for monitoring health, accessing data, and receiving support, helping users improve their well-being and make informed decisions about their health.

What is the ticker symbol for DarioHealth?

The ticker symbol for DarioHealth is NASDAQ:DRIO

Does DarioHealth pay dividends?

No, DarioHealth does not pay dividends

What sector is DarioHealth in?

DarioHealth is in the Healthcare sector

What industry is DarioHealth in?

DarioHealth is in the Health Information Services industry

What country is DarioHealth based in?

DarioHealth is headquartered in United States

When did DarioHealth go public?

DarioHealth's initial public offering (IPO) was on 14 March 2016

Is DarioHealth in the S&P 500?

No, DarioHealth is not included in the S&P 500 index

Is DarioHealth in the NASDAQ 100?

No, DarioHealth is not included in the NASDAQ 100 index

Is DarioHealth in the Dow Jones?

No, DarioHealth is not included in the Dow Jones index

When was DarioHealth's last earnings report?

DarioHealth's most recent earnings report was on 7 November 2024

When does DarioHealth report earnings?

The next expected earnings date for DarioHealth is 28 March 2025

Should I buy DarioHealth stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions